https://journals.lww.com/journaladdictionmedicine/Abstract/2018/12000/A_Multicountry_Updated_Assessment_of_the_Economic.10.aspx

Comment; Not much new in this article, admission that the data is scarce and likely under-represents the true burden which is significant despite probable under-reporting.

Costs for Children and Adults

Greenmyer, Jacob R., BS; Klug, Marilyn G., PhD; Kambeitz, Cassondra, BS; Popova, Svetlana, MD; Burd, Larry, PhD

Journal of Addiction Medicine: November/December 2018 – Volume 12 – Issue 6 – p 466–473

doi: 10.1097/ADM.0000000000000438

Original ResearchAim: To conduct a systematic review and quantitative analysis of the world literature on the economic impact of fetal alcohol spectrum disorder (FASD).

Methods: A comprehensive literature review was conducted using multiple electronic databases and reference materials.

Results: Thirty-two studies from 4 countries met the inclusion criteria (United States [n = 20], Canada [n = 9], Sweden [n = 2], and New Zealand [n = 1]). The studies reported the economic impact of FASD on health care, special education, residential care, criminal justice system, productivity losses due to morbidity and premature mortality, productivity losses of caregivers of children with FASD, and intangible costs. The economic estimates vary considerably due to the different methodologies used by different studies. The mean annual cost for children with FASD was estimated to be $22,810 and for adults $24,308. Residential costs for children with FASD were 4-fold greater than for adults with FASD. The costs of lost productivity for adults were 6.3-fold greater than for children.

Conclusions: The data on the economic burden of FASD are scarce, and the existing estimates likely underestimate the full economic impact of this disorder on the affected individuals, their caregivers, and society. However, the current research is sufficient to demonstrate that FASD is a serious public health problem associated with tremendous economic burden.

© 2018 American Society of Addiction Medicine

Dr. Raymond Oenbrink